Table 4.
Variables | HR (95% CI) | P-value | |
---|---|---|---|
Gender |
|
|
0.020 |
|
Female |
1.0 |
|
|
Male |
1.278 (1.040, 1.572) |
|
Age, years |
|
|
0.007 |
|
< 65 |
1.0 |
|
|
≧ 65 |
1.317 (1.078, 1.608) |
|
Location |
|
|
0.020 |
|
Colon |
1.0 |
|
|
Rectum |
1.267 (1.038, 1.547) |
|
Size, cm |
|
|
0.112 |
|
< 5 |
1.0 |
|
|
≧ 5 |
1.184 (0.961, 1.459) |
|
Preoperative serum CEA, ng/ml |
|
< 0.001 |
|
|
< 5.0 |
1.0 |
|
|
≧ 5.0 |
1.483 (1.203, 1.828) |
|
Depth of invasiona |
|
< 0.001 |
|
|
T1, T2 |
1.0 |
|
|
T3, T4 |
2.253 (1.534, 3.308) |
|
Lymph node metastasisa |
|
< 0.001 |
|
|
N0 |
1.0 |
|
|
N1, N2 |
2.427 (1.893, 3.105) |
|
Distant metastasisa |
|
< 0.001 |
|
|
M0 |
1.0 |
|
|
M1 |
4.165 (3.350, 5.179) |
|
Operating facility |
|
0.032 |
|
|
Center A |
1.0 |
|
|
Center B |
1.192 (1.002, 1.395) |
|
Histological type |
|
< 0.001 |
|
|
NMA |
1.0 |
|
MA | 2.226 (1.618, 3.062) |
aStaging of tumor (T), nodes (N), and metastases (M) [24]; HR, hazard ratio; CI, confidence interval; NMA, non-mucinous adenocarcinoma; MA, mucinous adenocarcinoma.